Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Alvarez

Showing results (561-570 of 582) with videos related to

Pageof 59
Sort By:
The Journal of Clinical Endocrinology and Metabolism|October 18, 2007
Pendred syndrome in two Galician families: insights into clinical phenotypes through cellular, genetic, and molecular studiesFernando Palos, María E R García-Rendueles, David Araujo-Vilar, et al.
Cancer Research|May 15, 2025
Targeting the Dependence on PIK3C3-mTORC1 Signaling in Dormancy-Prone Breast Cancer Cells Blunts Metastasis InitiationIslam E Elkholi, Amélie Robert, Camille Malouf, et al.
Cancer Research|January 8, 2025
Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy-Tolerant Persister Cells in ER+ Breast CancerSteven Tau, Mary D Chamberlin, Huijuan Yang, et al.
International Journal of Molecular Sciences|September 28, 2023
Role of Soluble ST2 Biomarker in Predicting Recurrence of Atrial Fibrillation after Electrical Cardioversion or Pulmonary Vein IsolationJavier García-Seara, Laila González Melchor, Javier Rodríguez García, et al.
Clinical Endocrinology|September 26, 2020
Molecular determinants of enhanced response to somatostatin receptor ligands after debulking in large GH-producing adenomasJoan Gil, Montserrat Marques-Pamies, Mireia Jordà, et al.
Ebiomedicine|April 13, 2019
Unmasking a new prognostic marker and therapeutic target from the GDNF-RET/PIT1/p14ARF/p53 pathway in acromegalyMiguel Chenlo, Iria A Rodriguez-Gomez, Ramon Serramito, et al.
Endocrinology|August 20, 2014
Somatotropinomas, but not nonfunctioning pituitary adenomas, maintain a functional apoptotic RET/Pit1/ARF/p53 pathway that is blocked by excess GDNFEsther Diaz-Rodriguez, Angela R Garcia-Rendueles, Alejandro Ibáñez-Costa, et al.
Neurology|March 6, 2024
Trans-Synaptic Degeneration in the Visual Pathway in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseLuca Bollo, Georgina Arrambide, Alvaro Cobo-Calvo, et al.
Endocrine-Related Cancer|April 18, 2020
Molecular profiling for acromegaly treatment: a validation studyManel Puig-Domingo, Joan Gil, Miguel Sampedro-Nuñez, et al.
Scientific Reports|June 1, 2022
Data mining analyses for precision medicine in acromegaly: a proof of conceptJoan Gil, Montserrat Marques-Pamies, Miguel Sampedro, et al.
Pageof 59

Showing results (561-570 of 582) with videos related to

Sort By:
Pageof 59
The Journal of Clinical Endocrinology and Metabolism|October 18, 2007
Pendred syndrome in two Galician families: insights into clinical phenotypes through cellular, genetic, and molecular studiesFernando Palos, María E R García-Rendueles, David Araujo-Vilar, et al.
Cancer Research|May 15, 2025
Targeting the Dependence on PIK3C3-mTORC1 Signaling in Dormancy-Prone Breast Cancer Cells Blunts Metastasis InitiationIslam E Elkholi, Amélie Robert, Camille Malouf, et al.
Cancer Research|January 8, 2025
Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy-Tolerant Persister Cells in ER+ Breast CancerSteven Tau, Mary D Chamberlin, Huijuan Yang, et al.
International Journal of Molecular Sciences|September 28, 2023
Role of Soluble ST2 Biomarker in Predicting Recurrence of Atrial Fibrillation after Electrical Cardioversion or Pulmonary Vein IsolationJavier García-Seara, Laila González Melchor, Javier Rodríguez García, et al.
Clinical Endocrinology|September 26, 2020
Molecular determinants of enhanced response to somatostatin receptor ligands after debulking in large GH-producing adenomasJoan Gil, Montserrat Marques-Pamies, Mireia Jordà, et al.
Ebiomedicine|April 13, 2019
Unmasking a new prognostic marker and therapeutic target from the GDNF-RET/PIT1/p14ARF/p53 pathway in acromegalyMiguel Chenlo, Iria A Rodriguez-Gomez, Ramon Serramito, et al.
Endocrinology|August 20, 2014
Somatotropinomas, but not nonfunctioning pituitary adenomas, maintain a functional apoptotic RET/Pit1/ARF/p53 pathway that is blocked by excess GDNFEsther Diaz-Rodriguez, Angela R Garcia-Rendueles, Alejandro Ibáñez-Costa, et al.
Neurology|March 6, 2024
Trans-Synaptic Degeneration in the Visual Pathway in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseLuca Bollo, Georgina Arrambide, Alvaro Cobo-Calvo, et al.
Endocrine-Related Cancer|April 18, 2020
Molecular profiling for acromegaly treatment: a validation studyManel Puig-Domingo, Joan Gil, Miguel Sampedro-Nuñez, et al.
Scientific Reports|June 1, 2022
Data mining analyses for precision medicine in acromegaly: a proof of conceptJoan Gil, Montserrat Marques-Pamies, Miguel Sampedro, et al.
Pageof 59